THURSDAY, May 5, 2022 (HealthDay News) — Two experimental vaccines show promise in protecting against infection with the “mono” virus, which also causes cancer and has been implicated as a potential trigger of multiple sclerosis, a new paper reports. Tested only in animals so far, the vaccines block two pathwaysContinue Reading
TUESDAY, May 3, 2022 (HealthDay News) — Black Americans are as likely to get multiple sclerosis (MS) as their white counterparts, but rates are much lower among Hispanic and Asian Americans, new research shows. The findings refute the long-held belief that MS is rare in Black people, according to theContinue Reading
THURSDAY, April 14, 2022 (HealthDay News) — In 2019 alone, multiple sclerosis (MS) cost Americans an estimated $85.4 billion, a new study finds. That amount included over $63 billion in direct medical costs and $22 billion in indirect non-medical costs. “The findings of this study help underscore the burden ofContinue Reading
THURSDAY, March 3, 2022 (HealthDay News) — Telemedicine was widely used by Americans with multiple sclerosis (MS) during the pandemic, and many were happy with the results, a new study finds. “The findings suggest that telehealth services were well liked during the pandemic. Because many individuals with MS have physicalContinue Reading
WEDNESDAY, March 2, 2022 (HealthDay News) — The Keto diet is a low-carb lover’s dream, but a new study suggests the popular eating plan may also improve some symptoms of multiple sclerosis (MS). MS is an autoimmune disease that occurs when your body attacks the insulation wrapped around its nerves,Continue Reading
MS patients who followed a keto diet for six months experienced physical and mental health improvements, new study finds.Continue Reading
THURSDAY, Feb. 10, 2022 (HealthDay News) — The mononucleosis virus, Epstein-Barr, has become a major suspect in the search for what causes multiple sclerosis. Now researchers are raising the next logical question — can we stop both MS and mononucleosis by preventing Epstein-Barr infections, which occur in 95% of adults?Continue Reading
TUESDAY, Feb. 1, 2022 (HealthDay News) — If you eat a lot of meat, you may be at increased risk for multiple sclerosis (MS), a new study suggests. MS is an autoimmune disease in which the body attacks the insulation around nerves. It’s not clear what triggers the attack, butContinue Reading
WEDNESDAY, Jan. 26, 2022 (HealthDay News) — A one-two punch from science has clearly tagged the mononucleosis virus, Epstein-Barr, as a major cause of multiple sclerosis. The Epstein-Barr virus (EBV) appears to trigger multiple sclerosis (MS) by tricking the immune systems of some into attacking their body’s own nerve cells,Continue Reading
FRIDAY, Jan. 14, 2022 (HealthDay News) — For years, researchers have suspected that the Epstein-Barr virus, best known for causing mononucleois, might also play a role in triggering multiple sclerosis. Now a new study strengthens the case. The study, of more than 10 million U.S. military personnel, found the riskContinue Reading
FRIDAY, Jan. 7, 2022 (HealthDay News) – Researchers in Austria say a new MRI technique may lead to faster diagnosis and treatment for people with multiple sclerosis. The technique can detect biochemical changes in the brains of people with MS early in their disease, according to findings published Jan. 4Continue Reading
THURSDAY, Dec. 9, 2021 (HealthDay News) — Children at risk for multiple sclerosis (MS) might find some protection from the disease by spending more time in the sun, a small study suggests. Although MS is rare in children and young adults, those with relatives who have the condition have increasedContinue Reading
THURSDAY, Nov. 11, 2021 (HealthDay News) — Multiple sclerosis patients might be able to think more clearly and move more easily if they regularly undergo whole-body vibration training, a new pilot study reports. A small group of MS patients who experienced vibration training showed improvements in decision making, information processing,Continue Reading
THURSDAY, Sept. 16, 2021 (HealthDay News) — Multiple sclerosis (MS) patients undergoing a treatment that depletes a type of immune cell that fuels MS attacks still have a strong response to mRNA COVID-19 vaccines, a new study finds. “The message from this study is clear — it is worthwhile forContinue Reading